Clinical Trial Update: Clinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic Hypogonadism [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating subcutaneous testosterone implants for symptomatic hypogonadism in men. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Male Hypogonadism
• Testosterone Deficiency

Drugs mentioned

• Testosterone implants (testosterone pellet)

Snippet

Sponsor: University of Sao Paulo | Conditions: Male Hypogonadism, Testosterone Deficiency | Phase 2 | Status: NOT_YET_RECRUITING